Breast cancer cell adhesion and migration through a normal human umbilical vein endothelial cell (HUVEC) monolayer is significantly reduced by inhibiting CXCR4 or treating ECs with an SDF-1 neutralizing antibody. The gene discussed is CXCL12; the disease is breast cancer.